Trial Profile
A double-blind, cross-over patient preference study of frovatriptan versus rizatriptan for the acute treatment of migraine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jun 2019
Price :
$35
*
At a glance
- Drugs Frovatriptan (Primary) ; Rizatriptan
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Menarini
- 17 Jun 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 01 Jun 2011 New trial record